BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22569564)

  • 1. ITN protection, MSP1 antibody levels and malaria episodes in young children of rural Burkina Faso.
    Kynast-Wolf G; Wakilzadeh W; Coulibaly B; Schnitzler P; Traoré C; Becher H; Müller O
    Acta Trop; 2012 Aug; 123(2):117-22. PubMed ID: 22569564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of malaria prevention with insecticide-treated mosquito nets on morbidity and mortality in African children: randomised controlled trial.
    Louis VR; Bals J; Tiendrebéogo J; Bountogo M; Ramroth H; De Allegri M; Traoré C; Beiersmann C; Coulibaly B; Yé M; Jahn A; Becher H; Müller O
    Trop Med Int Health; 2012 Jun; 17(6):733-41. PubMed ID: 22519853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas.
    Adu B; Cherif MK; Bosomprah S; Diarra A; Arthur FK; Dickson EK; Corradin G; Cavanagh DR; Theisen M; Sirima SB; Nebie I; Dodoo D
    Malar J; 2016 Feb; 15():123. PubMed ID: 26921176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria incidence during early childhood in rural Burkina Faso: Analysis of a birth cohort protected with insecticide-treated mosquito nets.
    Wehner S; Stieglbauer G; Traoré C; Sie A; Becher H; Müller O
    Acta Trop; 2017 Nov; 175():78-83. PubMed ID: 28336268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria.
    Aubouy A; Migot-Nabias F; Deloron P
    Infect Genet Evol; 2007 Mar; 7(2):147-54. PubMed ID: 16890498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein 1 in a transmigrant population requires multiple infections.
    Murhandarwati EE; Black CG; Wang L; Weisman S; Koning-Ward TF; Baird JK; Tjitra E; Richie TL; Crabb BS; Coppel RL
    J Infect Dis; 2008 Oct; 198(8):1212-8. PubMed ID: 18717639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of impregnated curtains does not affect antibody responses against Plasmodium falciparum and complexity of infecting parasite populations in children from Burkina Faso.
    Bolad A; Nebié I; Esposito F; Berzins K
    Acta Trop; 2004 May; 90(3):237-47. PubMed ID: 15099810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD36 c.1264 T>G null mutation impairs acquisition of IgG antibodies to Plasmodium falciparum MSP1₁₉ antigen and is associated with higher malaria incidences in Tanzanian children.
    Kajeguka D; Mwanziva C; Daou M; Ndaro A; Matondo S; Mbugi E; Dolmans W; Chilongola J
    Scand J Immunol; 2012 Mar; 75(3):355-60. PubMed ID: 22050542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to allelic variants of 19kDa fragment of MSP-1: recognition of a variant and protection associated with ethnicity in Assam, India.
    Lourembam SD; Baruah S
    Vaccine; 2012 Jan; 30(4):767-73. PubMed ID: 22133506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Olyset Duo, a bednet containing pyriproxyfen and permethrin, versus a permethrin-only net against clinical malaria in an area with highly pyrethroid-resistant vectors in rural Burkina Faso: a cluster-randomised controlled trial.
    Tiono AB; Ouédraogo A; Ouattara D; Bougouma EC; Coulibaly S; Diarra A; Faragher B; Guelbeogo MW; Grisales N; Ouédraogo IN; Ouédraogo ZA; Pinder M; Sanon S; Smith T; Vanobberghen F; Sagnon N; Ranson H; Lindsay SW
    Lancet; 2018 Aug; 392(10147):569-580. PubMed ID: 30104047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission.
    Torres KJ; Clark EH; Hernandez JN; Soto-Cornejo KE; Gamboa D; Branch OH
    Malar J; 2008 Sep; 7():173. PubMed ID: 18782451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses.
    Conway DJ; Cavanagh DR; Tanabe K; Roper C; Mikes ZS; Sakihama N; Bojang KA; Oduola AM; Kremsner PG; Arnot DE; Greenwood BM; McBride JS
    Nat Med; 2000 Jun; 6(6):689-92. PubMed ID: 10835687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE antibodies to Plasmodium falciparum and severity of malaria in children of one ethnic group living in Burkina Faso.
    Calissano C; Modiano D; Sirima BS; Konate A; Sanou I; Sawadogo A; Perlmann H; Troye-Blomberg M; Perlmann P
    Am J Trop Med Hyg; 2003 Jul; 69(1):31-5. PubMed ID: 12932093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional study of specific antibodies to a polymorphic Plasmodium falciparum antigen and of parasite antigen genotypes in school children on the slope of Mount Cameroon.
    Kimbi HK; Tetteh KK; Polley SD; Conway DJ
    Trans R Soc Trop Med Hyg; 2004 May; 98(5):284-9. PubMed ID: 15109551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa.
    Nebie I; Diarra A; Ouedraogo A; Soulama I; Bougouma EC; Tiono AB; Konate AT; Chilengi R; Theisen M; Dodoo D; Remarque E; Bosomprah S; Milligan P; Sirima SB
    Infect Immun; 2008 Feb; 76(2):759-66. PubMed ID: 18070896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific antibodies against Plasmodium falciparum antigens in immune subjects: II. Screening of responses against the merozoite major surface antigen (MSP!)].
    Nguer CM; Diouf A; Diallo TO; Dieye A; Tall A; Diouf B; Molez JF; Trape JF; Perraut R; Garraud O
    Dakar Med; 1997; 42(2):106-10. PubMed ID: 9827130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sero-epidemiological evaluation of Plasmodium falciparum malaria in Senegal.
    Sylla K; Tine RC; Ndiaye M; Sow D; Sarr A; Mbuyi ML; Diouf I; Lô AC; Abiola A; Seck MC; Ndiaye M; Badiane AS; N'Diaye JL; Ndiaye D; Faye O; Dieng T; Dieng Y; Ndir O; Gaye O; Faye B
    Malar J; 2015 Jul; 14():275. PubMed ID: 26173958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for vaccine development.
    Yuen D; Leung WH; Cheung R; Hashimoto C; Ng SF; Ho W; Hui G
    Vaccine; 2007 Jan; 25(3):490-9. PubMed ID: 16949181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG subclass antibodies to three variants of Plasmodium falciparum merozoite surface protein-1 (PfMSP-1(19)) in an area with unstable malaria transmission in Iran.
    Mehrizi AA; Asgharpour S; Salmanian AH; Djadid ND; Zakeri S
    Acta Trop; 2011 Aug; 119(2-3):84-90. PubMed ID: 21609709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.